SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from WINDROSE MEDICAL PROPERTIES TRUST (CIK 0001173942) — Aug 19, 2005

WINDROSE MEDICAL PROPERTIES TRUST (CIK 0001173942)
Date: Aug. 19, 2005 · CIK: 0001173942 · Accession: 0000950144-05-008961

AI Filing Summary & Sentiment

File numbers found in text: 333-125213

Date
August 18, 2005
Author
Windrose Medical Properties Trust
Form
CORRESP
Company
WINDROSE MEDICAL PROPERTIES TRUST (CIK 0001173942)

Letter

VIA EDGAR AND FACSIMILE (202/772-9209) Securities and Exchange Commission Washington, D.C. 20549 Attention: Ms. Karen J. Garnett Windrose Medical Properties Trust Registration Statement on Form S-3 (File No. 333-125213)

Dear Ms. Garnett:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Windrose Medical Properties Trust hereby requests acceleration of effectiveness of the above-captioned Registration Statement to 11:00 a.m., Eastern time on Tuesday, August 23, 2005 or as soon thereafter as practicable.

In connection with this request for acceleration of effectiveness, the Company acknowledges the following:

•

should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

•

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

•

the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very truly yours,
Windrose Medical Properties Trust

Show Raw Text
CORRESP
1
filename1.htm

WINDROSE MEDICAL PROPERTIES TRUST

WINDROSE MEDICAL PROPERTIES TRUST

3502 Woodview Trace, Suite 210

Indianapolis, IN 46268

August 18, 2005

VIA EDGAR AND FACSIMILE (202/772-9209)

Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, D.C. 20549

Attention: Ms. Karen J. Garnett

Windrose Medical Properties Trust

Registration Statement on Form S-3 (File No. 333-125213)

Dear Ms. Garnett:

     Pursuant to Rule 461 under the Securities Act of 1933, as amended, Windrose Medical Properties
Trust hereby requests acceleration of effectiveness of the above-captioned Registration Statement
to 11:00 a.m., Eastern time on Tuesday, August 23, 2005 or as soon thereafter as practicable.

     In connection with this request for acceleration of effectiveness, the Company acknowledges
the following:

    •

    should the Commission or the staff, acting pursuant to delegated authority, declare
the filing effective, it does not foreclose the Commission from taking any action with
respect to the filing;

    •

    the action of the Commission or the staff, acting pursuant to delegated authority,
in declaring the filing effective, does not relieve the Company from its full
responsibility for the adequacy and accuracy of the disclosure in the filing; and

    •

    the Company may not assert this action as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.

    Very truly yours,

Windrose Medical Properties Trust

    By:
    /s/ Frederick L. Farrar

    Name:
    Frederick L. Farrar

    Title:
    President, Chief Operating Officer,
Treasurer and Interim Chief Financial Officer

cc: Jennifer Gowetski